SBIA
ETRM

Sheaff Brock Investment Advisors’s EnteroMedics Inc. ETRM Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-19
Closed -$3K – 737
2015
Q4 		$3K Buy
+19
New +$3.94K ﹤0.01% 669

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Sheaff Brock Investment Advisors's ETRM Position: Q1 2016 in Review

Sheaff Brock Investment Advisors sold out of EnteroMedics Inc. (ETRM) in Q1 2016, closing a stake of 19 shares — an estimated $3K sold.

Sheaff Brock Investment Advisors first reported a position in ETRM in Q4 2015 and held it in 1 quarter. The position peaked at $3K in Q4 2015. 26 funds tracked by Wall St. Rank hold ETRM as of Q1 2016.

  • Sheaff Brock Investment Advisors reported no remaining EnteroMedics Inc. position as of Q1 2016 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 19 EnteroMedics Inc. shares in Q1 2016, an estimated $3K.
  • Sheaff Brock Investment Advisors first reported a position in EnteroMedics Inc. in Q4 2015 and held it in 1 quarter.
  • Sheaff Brock Investment Advisors's EnteroMedics Inc. position peaked at $3K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2016.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2016, filed 25 Apr 2016.